ELIZABETH JACKSON

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant GLENWOOD SPGS, CO NPI 1497065627

General Payments — all program years on this page

$1,523.08

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 76
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $393.75 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $393.7520

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $323.4713
2022 $370.8920
2023 $434.9723
2024 $393.7520

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086369753 Bayer Healthcare Pharmaceuticals Inc. $19.73 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087125000 Novartis Pharmaceuticals Corporation $23.13 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092654235 Boston Scientific Corporation $28.63 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101381558 E.R. Squibb & Sons, L.L.C. $13.27 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101381572 E.R. Squibb & Sons, L.L.C. $14.05 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104223461 AstraZeneca Pharmaceuticals LP $22.72 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104314090 AstraZeneca Pharmaceuticals LP $19.67 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104407499 AstraZeneca Pharmaceuticals LP $21.41 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105348159 AstraZeneca Pharmaceuticals LP $18.89 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105674633 AstraZeneca Pharmaceuticals LP $21.79 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107389040 ABBVIE INC. $23.01 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107389042 ABBVIE INC. $21.10 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107389044 ABBVIE INC. $15.14 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114715325 Exact Sciences Corporation $21.66 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114715332 Exact Sciences Corporation $20.62 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114715338 Exact Sciences Corporation $20.33 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114715344 Exact Sciences Corporation $17.86 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119102528 Otsuka America Pharmaceutical, Inc. $20.92 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132090311 PFIZER INC. $16.67 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135550555 Lilly USA, LLC $13.15 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.